TY - JOUR AU - Ansell, J. AU - Hirsh, J. AU - Hylek, E. AU - Jacobson, A. AU - Crowther, M. AU - Palareti, G. PY - 2008 DA - 2008// TI - Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition) JO - Chest VL - 133 UR - https://doi.org/10.1378/chest.08-0670 DO - 10.1378/chest.08-0670 ID - Ansell2008 ER - TY - JOUR AU - Bjorck, F. AU - Renlund, H. AU - Lip, G. Y. AU - Wester, P. AU - Svensson, P. J. AU - Sjalander, A. PY - 2016 DA - 2016// TI - Outcomes in a warfarin-treated population with atrial fibrillation JO - JAMA Cardiol VL - 1 UR - https://doi.org/10.1001/jamacardio.2016.0199 DO - 10.1001/jamacardio.2016.0199 ID - Bjorck2016 ER - TY - JOUR AU - Oake, N. AU - Fergusson, D. A. AU - Forster, A. J. AU - van Walraven, C. PY - 2007 DA - 2007// TI - Frequency of adverse events in patients with poor anticoagulation: a meta-analysis JO - CMAJ VL - 176 UR - https://doi.org/10.1503/cmaj.061523 DO - 10.1503/cmaj.061523 ID - Oake2007 ER - TY - JOUR AU - Oake, N. AU - Jennings, A. AU - Forster, A. J. AU - Fergusson, D. AU - Doucette, S. AU - van Walraven, C. PY - 2008 DA - 2008// TI - Anticoagulation intensity and outcomes among patients prescribed oral anticoagulant therapy: a systematic review and meta-analysis JO - CMAJ VL - 179 UR - https://doi.org/10.1503/cmaj.080171 DO - 10.1503/cmaj.080171 ID - Oake2008 ER - TY - JOUR AU - Adelborg, K. AU - Grove, E. L. AU - Sundboll, J. AU - Laursen, M. AU - Schmidt, M. PY - 2016 DA - 2016// TI - Sixteen-year nationwide trends in antithrombotic drug use in Denmark and its correlation with landmark studies JO - Heart VL - 102 UR - https://doi.org/10.1136/heartjnl-2016-309402 DO - 10.1136/heartjnl-2016-309402 ID - Adelborg2016 ER - TY - JOUR AU - Lopez-Lopez, J. A. AU - Sterne, J. A. C. AU - Thom, H. H. Z. AU - Higgins, J. P. T. AU - Hingorani, A. D. AU - Okoli, G. N. PY - 2017 DA - 2017// TI - Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis JO - BMJ VL - 359 UR - https://doi.org/10.1136/bmj.j5058 DO - 10.1136/bmj.j5058 ID - Lopez-Lopez2017 ER - TY - JOUR AU - Oktay, K. PY - 2015 DA - 2015// TI - Will NOACs become the new standard of care in anticoagulation therapy? JO - Int J Cardiovasc Acad VL - 1 UR - https://doi.org/10.1016/j.ijcac.2015.06.007 DO - 10.1016/j.ijcac.2015.06.007 ID - Oktay2015 ER - TY - STD TI - Bruins Slot KM, Berge E. Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation. Cochrane Database Syst Rev. 2013;8 https://doi.org/10.1002/14651858.CD14008980.pub14651852. ID - ref8 ER - TY - STD TI - Robertson L, Kesteven P, McCaslin JE. Oral direct thrombin inhibitors or oral factor Xa inhibitors for the treatment of pulmonary embolism. Cochrane Database Syst Rev. 2015;12 https://doi.org/10.1002/14651858.CD14010957.pub14651852. ID - ref9 ER - TY - STD TI - Salazar CA, del Aguila D, Cordova EG. Direct thrombin inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in people with non-valvular atrial fibrillation. Cochrane Database Syst Rev. 2014;3 https://doi.org/10.1002/14651858.CD14009893.pub14651852. ID - ref10 ER - TY - JOUR AU - Al-Horani, R. A. AU - Desai, U. R. PY - 2016 DA - 2016// TI - Factor XIa inhibitors: a review of the patent literature JO - Expert Opin Ther Pat VL - 26 UR - https://doi.org/10.1517/13543776.2016.1154045 DO - 10.1517/13543776.2016.1154045 ID - Al-Horani2016 ER - TY - JOUR AU - Buller, H. R. AU - Bethune, C. AU - Bhanot, S. AU - Gailani, D. AU - Monia, B. P. AU - Raskob, G. E. PY - 2015 DA - 2015// TI - Factor XI antisense oligonucleotide for prevention of venous thrombosis JO - N Engl J Med VL - 372 UR - https://doi.org/10.1056/NEJMoa1405760 DO - 10.1056/NEJMoa1405760 ID - Buller2015 ER - TY - JOUR AU - Jackson, L. R. AU - Becker, R. C. PY - 2014 DA - 2014// TI - Novel oral anticoagulants: pharmacology, coagulation measures, and considerations for reversal JO - J Thromb Thrombolysis VL - 37 UR - https://doi.org/10.1007/s11239-013-0958-0 DO - 10.1007/s11239-013-0958-0 ID - Jackson2014 ER - TY - JOUR AU - Brouwers, H. B. AU - Chang, Y. AU - Falcone, G. J. AU - Cai, X. AU - Ayres, A. M. AU - Battey, T. W. PY - 2014 DA - 2014// TI - Predicting hematoma expansion after primary intracerebral hemorrhage JO - JAMA Neurol VL - 71 UR - https://doi.org/10.1001/jamaneurol.2013.5433 DO - 10.1001/jamaneurol.2013.5433 ID - Brouwers2014 ER - TY - JOUR AU - Cucchiara, B. AU - Messe, S. AU - Sansing, L. AU - Kasner, S. AU - Lyden, P. AU - Investigators, C. PY - 2008 DA - 2008// TI - Hematoma growth in oral anticoagulant related intracerebral hemorrhage JO - Stroke VL - 39 UR - https://doi.org/10.1161/STROKEAHA.108.520668 DO - 10.1161/STROKEAHA.108.520668 ID - Cucchiara2008 ER - TY - JOUR AU - Rosand, J. AU - Eckman, M. H. AU - Knudsen, K. A. AU - Singer, D. E. AU - Greenberg, S. M. PY - 2004 DA - 2004// TI - The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage JO - Arch Intern Med VL - 164 UR - https://doi.org/10.1001/archinte.164.8.880 DO - 10.1001/archinte.164.8.880 ID - Rosand2004 ER - TY - JOUR AU - Dowlatshahi, D. AU - Butcher, K. S. AU - Asdaghi, N. AU - Nahirniak, S. AU - Bernbaum, M. L. AU - Giulivi, A. PY - 2012 DA - 2012// TI - Poor prognosis in warfarin-associated intracranial hemorrhage despite anticoagulation reversal JO - Stroke VL - 43 UR - https://doi.org/10.1161/STROKEAHA.112.652065 DO - 10.1161/STROKEAHA.112.652065 ID - Dowlatshahi2012 ER - TY - JOUR AU - Davis, S. M. AU - Broderick, J. AU - Hennerici, M. AU - Brun, N. C. AU - Diringer, M. N. AU - Mayer, S. A. PY - 2006 DA - 2006// TI - Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage JO - Neurology VL - 66 UR - https://doi.org/10.1212/01.wnl.0000208408.98482.99 DO - 10.1212/01.wnl.0000208408.98482.99 ID - Davis2006 ER - TY - JOUR AU - Delcourt, C. AU - Huang, Y. AU - Arima, H. AU - Chalmers, J. AU - Davis, S. M. AU - Heeley, E. L. PY - 2012 DA - 2012// TI - Hematoma growth and outcomes in intracerebral hemorrhage: the INTERACT1 study JO - Neurology VL - 79 UR - https://doi.org/10.1212/WNL.0b013e318260cbba DO - 10.1212/WNL.0b013e318260cbba ID - Delcourt2012 ER - TY - JOUR AU - Dowlatshahi, D. AU - Demchuk, A. M. AU - Flaherty, M. L. AU - Ali, M. AU - Lyden, P. L. AU - Smith, E. E. PY - 2011 DA - 2011// TI - Defining hematoma expansion in intracerebral hemorrhage: relationship with patient outcomes JO - Neurology VL - 76 UR - https://doi.org/10.1212/WNL.0b013e3182143317 DO - 10.1212/WNL.0b013e3182143317 ID - Dowlatshahi2011 ER - TY - JOUR AU - Leira, R. AU - Davalos, A. AU - Silva, Y. AU - Gil-Peralta, A. AU - Tejada, J. AU - Garcia, M. PY - 2004 DA - 2004// TI - Early neurologic deterioration in intracerebral hemorrhage: predictors and associated factors JO - Neurology VL - 63 UR - https://doi.org/10.1212/01.WNL.0000133204.81153.AC DO - 10.1212/01.WNL.0000133204.81153.AC ID - Leira2004 ER - TY - JOUR AU - Kuramatsu, J. B. AU - Gerner, S. T. AU - Schellinger, P. D. AU - Glahn, J. AU - Endres, M. AU - Sobesky, J. PY - 2015 DA - 2015// TI - Anticoagulant reversal, blood pressure levels, and anticoagulant resumption in patients with anticoagulation-related intracerebral hemorrhage JO - JAMA VL - 313 UR - https://doi.org/10.1001/jama.2015.0846 DO - 10.1001/jama.2015.0846 ID - Kuramatsu2015 ER - TY - JOUR AU - Caldeira, D. AU - Rodrigues, F. B. AU - Barra, M. AU - Santos, A. T. AU - de Abreu, D. AU - Goncalves, N. PY - 2015 DA - 2015// TI - Non-vitamin K antagonist oral anticoagulants and major bleeding-related fatality in patients with atrial fibrillation and venous thromboembolism: a systematic review and meta-analysis JO - Heart VL - 101 UR - https://doi.org/10.1136/heartjnl-2015-307489 DO - 10.1136/heartjnl-2015-307489 ID - Caldeira2015 ER - TY - JOUR AU - Marques-Matos, C. AU - Alves, J. N. AU - Marto, J. P. AU - Ribeiro, J. A. AU - Monteiro, A. AU - Araujo, J. PY - 2017 DA - 2017// TI - POST-NOAC: Portuguese observational study of intracranial hemorrhage on non-vitamin K antagonist oral anticoagulants JO - Int J Stroke VL - 12 UR - https://doi.org/10.1177/1747493016681021 DO - 10.1177/1747493016681021 ID - Marques-Matos2017 ER - TY - JOUR AU - Takahashi, H. AU - Jimbo, Y. AU - Takano, H. AU - Abe, H. AU - Sato, M. AU - Fujii, Y. PY - 2016 DA - 2016// TI - Intracerebral hematoma occurring during warfarin versus non-vitamin K antagonist oral anticoagulant therapy JO - Am J Cardiol VL - 118 UR - https://doi.org/10.1016/j.amjcard.2016.04.034 DO - 10.1016/j.amjcard.2016.04.034 ID - Takahashi2016 ER - TY - JOUR AU - von der Brelie, C. AU - Doukas, A. AU - Naumann, R. AU - Dempfle, A. AU - Larsen, N. AU - Synowitz, M. PY - 2017 DA - 2017// TI - Clinical and radiological course of intracerebral haemorrhage associated with the new non-vitamin K anticoagulants JO - Acta Neurochir VL - 159 UR - https://doi.org/10.1007/s00701-016-3026-7 DO - 10.1007/s00701-016-3026-7 ID - von der Brelie2017 ER - TY - JOUR AU - Wilson, D. AU - Charidimou, A. AU - Shakeshaft, C. AU - Ambler, G. AU - White, M. AU - Cohen, H. PY - 2016 DA - 2016// TI - Volume and functional outcome of intracerebral hemorrhage according to oral anticoagulant type JO - Neurology VL - 86 UR - https://doi.org/10.1212/WNL.0000000000002310 DO - 10.1212/WNL.0000000000002310 ID - Wilson2016 ER - TY - JOUR AU - Purrucker, J. C. AU - Haas, K. AU - Rizos, T. AU - Khan, S. AU - Wolf, M. AU - Hennerici, M. G. PY - 2016 DA - 2016// TI - Early clinical and radiological course, management, and outcome of intracerebral hemorrhage related to new oral anticoagulants JO - JAMA Neurol VL - 73 UR - https://doi.org/10.1001/jamaneurol.2015.3682 DO - 10.1001/jamaneurol.2015.3682 ID - Purrucker2016 ER - TY - JOUR AU - Wilson, D. AU - Seiffge, D. J. AU - Traenka, C. AU - Basir, G. AU - Purrucker, J. C. AU - Rizos, T. PY - 2017 DA - 2017// TI - Outcome of intracerebral hemorrhage associated with different oral anticoagulants JO - Neurology VL - 88 UR - https://doi.org/10.1212/WNL.0000000000003886 DO - 10.1212/WNL.0000000000003886 ID - Wilson2017 ER - TY - JOUR AU - Skaistis, J. AU - Tagami, T. PY - 2015 DA - 2015// TI - Risk of fatal bleeding in episodes of major bleeding with new oral anticoagulants and vitamin K antagonists: a systematic review and meta-analysis JO - PLoS One VL - 10 UR - https://doi.org/10.1371/journal.pone.0137444 DO - 10.1371/journal.pone.0137444 ID - Skaistis2015 ER - TY - JOUR AU - Franchini, M. AU - Lippi, G. PY - 2010 DA - 2010// TI - Prothrombin complex concentrates: an update JO - Blood Transfus VL - 8 ID - Franchini2010 ER - TY - JOUR AU - Keeling, D. AU - Baglin, T. AU - Tait, C. AU - Watson, H. AU - Perry, D. AU - Baglin, C. PY - 2011 DA - 2011// TI - Guidelines on oral anticoagulation with warfarin - fourth edition JO - Br J Haematol VL - 154 UR - https://doi.org/10.1111/j.1365-2141.2011.08753.x DO - 10.1111/j.1365-2141.2011.08753.x ID - Keeling2011 ER - TY - JOUR AU - Hylek, E. M. AU - Regan, S. AU - Go, A. S. AU - Hughes, R. A. AU - Singer, D. E. AU - Skates, S. J. PY - 2001 DA - 2001// TI - Clinical predictors of prolonged delay in return of the international normalized ratio to within the therapeutic range after excessive anticoagulation with warfarin JO - Ann Intern Med VL - 135 UR - https://doi.org/10.7326/0003-4819-135-6-200109180-00008 DO - 10.7326/0003-4819-135-6-200109180-00008 ID - Hylek2001 ER - TY - JOUR AU - Schulman, S. AU - Elbazi, R. AU - Zondag, M. AU - O'Donnell, M. PY - 2008 DA - 2008// TI - Clinical factors influencing normalization of prothrombin time after stopping warfarin: a retrospective cohort study JO - Thromb J VL - 6 UR - https://doi.org/10.1186/1477-9560-6-15 DO - 10.1186/1477-9560-6-15 ID - Schulman2008 ER - TY - JOUR AU - Lubetsky, A. AU - Yonath, H. AU - Olchovsky, D. AU - Loebstein, R. AU - Halkin, H. AU - Ezra, D. PY - 2003 DA - 2003// TI - Comparison of oral vs intravenous phytonadione (vitamin K1) in patients with excessive anticoagulation: a prospective randomized controlled study JO - Arch Intern Med VL - 163 UR - https://doi.org/10.1001/archinte.163.20.2469 DO - 10.1001/archinte.163.20.2469 ID - Lubetsky2003 ER - TY - JOUR AU - Patel, R. J. AU - Witt, D. M. AU - Saseen, J. J. AU - Tillman, D. J. AU - Wilkinson, D. S. PY - 2000 DA - 2000// TI - Randomized, placebo-controlled trial of oral phytonadione for excessive anticoagulation JO - Pharmacotherapy VL - 20 UR - https://doi.org/10.1592/phco.20.15.1159.34585 DO - 10.1592/phco.20.15.1159.34585 ID - Patel2000 ER - TY - JOUR AU - Watson, H. G. AU - Baglin, T. AU - Laidlaw, S. L. AU - Makris, M. AU - Preston, F. E. PY - 2001 DA - 2001// TI - A comparison of the efficacy and rate of response to oral and intravenous vitamin K in reversal of over-anticoagulation with warfarin JO - Br J Haematol VL - 115 UR - https://doi.org/10.1046/j.1365-2141.2001.03070.x DO - 10.1046/j.1365-2141.2001.03070.x ID - Watson2001 ER - TY - JOUR PY - 1996 DA - 1996// TI - A report by the American Society of Anesthesiologists Task Force on Blood Component Therapy JO - Anesthesiology VL - 84 UR - https://doi.org/10.1097/00000542-199603000-00032 DO - 10.1097/00000542-199603000-00032 ID - ref38 ER - TY - JOUR AU - Ahmed, N. AU - Steiner, T. AU - Caso, V. AU - Wahlgren, N. PY - 2017 DA - 2017// TI - Recommendations from the ESO-Karolinska Stroke Update Conference, Stockholm 13–15 November 2016 JO - European Stroke J VL - 2 UR - https://doi.org/10.1177/2396987317699144 DO - 10.1177/2396987317699144 ID - Ahmed2017 ER - TY - JOUR AU - Yasaka, M. AU - Sakata, T. AU - Minematsu, K. AU - Naritomi, H. PY - 2002 DA - 2002// TI - Correction of INR by prothrombin complex concentrate and vitamin K in patients with warfarin related hemorrhagic complication JO - Thromb Res VL - 108 UR - https://doi.org/10.1016/S0049-3848(02)00402-4 DO - 10.1016/S0049-3848(02)00402-4 ID - Yasaka2002 ER - TY - JOUR AU - Marshall, A. L. AU - Levine, M. AU - Howell, M. L. AU - Chang, Y. AU - Riklin, E. AU - Parry, B. A. PY - 2016 DA - 2016// TI - Dose-associated pulmonary complication rates after fresh frozen plasma administration for warfarin reversal JO - J Thromb Haemost VL - 14 UR - https://doi.org/10.1111/jth.13212 DO - 10.1111/jth.13212 ID - Marshall2016 ER - TY - JOUR AU - Milling, T. J. AU - Refaai, M. A. AU - Sarode, R. AU - Lewis, B. AU - Mangione, A. AU - Durn, B. L. PY - 2016 DA - 2016// TI - Safety of a four-factor prothrombin complex concentrate versus plasma for vitamin K antagonist reversal: an integrated analysis of two phase IIIb clinical trials JO - Acad Emerg Med VL - 23 UR - https://doi.org/10.1111/acem.12911 DO - 10.1111/acem.12911 ID - Milling2016 ER - TY - JOUR AU - Frontera, J. A. AU - Gordon, E. AU - Zach, V. AU - Jovine, M. AU - Uchino, K. AU - Hussain, M. S. PY - 2014 DA - 2014// TI - Reversal of coagulopathy using prothrombin complex concentrates is associated with improved outcome compared to fresh frozen plasma in warfarin-associated intracranial hemorrhage JO - Neurocrit Care VL - 21 UR - https://doi.org/10.1007/s12028-014-9972-0 DO - 10.1007/s12028-014-9972-0 ID - Frontera2014 ER - TY - JOUR AU - Hanger, H. C. AU - Geddes, J. A. AU - Wilkinson, T. J. AU - Lee, M. AU - Baker, A. E. PY - 2013 DA - 2013// TI - Warfarin-related intracerebral haemorrhage: better outcomes when reversal includes prothrombin complex concentrates JO - Intern Med J VL - 43 UR - https://doi.org/10.1111/imj.12034 DO - 10.1111/imj.12034 ID - Hanger2013 ER - TY - JOUR AU - Hickey, M. AU - Gatien, M. AU - Taljaard, M. AU - Aujnarain, A. AU - Giulivi, A. AU - Perry, J. J. PY - 2013 DA - 2013// TI - Outcomes of urgent warfarin reversal with frozen plasma versus prothrombin complex concentrate in the emergency department JO - Circulation VL - 128 UR - https://doi.org/10.1161/CIRCULATIONAHA.113.001875 DO - 10.1161/CIRCULATIONAHA.113.001875 ID - Hickey2013 ER - TY - JOUR AU - Huttner, H. B. AU - Schellinger, P. D. AU - Hartmann, M. AU - Kohrmann, M. AU - Juettler, E. AU - Wikner, J. PY - 2006 DA - 2006// TI - Hematoma growth and outcome in treated neurocritical care patients with intracerebral hemorrhage related to oral anticoagulant therapy: comparison of acute treatment strategies using vitamin K, fresh frozen plasma, and prothrombin complex concentrates JO - Stroke VL - 37 UR - https://doi.org/10.1161/01.STR.0000221786.81354.d6 DO - 10.1161/01.STR.0000221786.81354.d6 ID - Huttner2006 ER - TY - JOUR AU - Woo, C. H. AU - Patel, N. AU - Conell, C. AU - Rao, V. A. AU - Faigeles, B. S. AU - Patel, M. C. PY - 2014 DA - 2014// TI - Rapid warfarin reversal in the setting of intracranial hemorrhage: a comparison of plasma, recombinant activated factor VII, and prothrombin complex concentrate JO - World Neurosurg VL - 81 UR - https://doi.org/10.1016/j.wneu.2012.12.002 DO - 10.1016/j.wneu.2012.12.002 ID - Woo2014 ER - TY - JOUR AU - Kushimoto, S. AU - Fukuoka, T. AU - Kimura, A. AU - Toyoda, K. AU - Brainsky, A. AU - Harman, A. PY - 2017 DA - 2017// TI - Efficacy and safety of a 4-factor prothrombin complex concentrate for rapid vitamin K antagonist reversal in Japanese patients presenting with major bleeding or requiring urgent surgical or invasive procedures: a prospective, open-label, single-arm phase 3b study JO - Int J Hematol VL - 106 UR - https://doi.org/10.1007/s12185-017-2311-4 DO - 10.1007/s12185-017-2311-4 ID - Kushimoto2017 ER - TY - JOUR AU - Goldstein, J. N. AU - Refaai, M. A. AU - Milling, T. J. AU - Lewis, B. AU - Goldberg-Alberts, R. AU - Hug, B. A. PY - 2015 DA - 2015// TI - Four-factor prothrombin complex concentrate versus plasma for rapid vitamin K antagonist reversal in patients needing urgent surgical or invasive interventions: a phase 3b, open-label, non-inferiority, randomised trial JO - Lancet VL - 385 UR - https://doi.org/10.1016/S0140-6736(14)61685-8 DO - 10.1016/S0140-6736(14)61685-8 ID - Goldstein2015 ER - TY - JOUR AU - Sarode, R. AU - Milling, T. J. AU - Refaai, M. A. AU - Mangione, A. AU - Schneider, A. AU - Durn, B. L. PY - 2013 DA - 2013// TI - Efficacy and safety of a 4-factor prothrombin complex concentrate in patients on vitamin K antagonists presenting with major bleeding: a randomized, plasma-controlled, phase IIIb study JO - Circulation VL - 128 UR - https://doi.org/10.1161/CIRCULATIONAHA.113.002283 DO - 10.1161/CIRCULATIONAHA.113.002283 ID - Sarode2013 ER - TY - JOUR AU - Steiner, T. AU - Poli, S. AU - Griebe, M. AU - Husing, J. AU - Hajda, J. AU - Freiberger, A. PY - 2016 DA - 2016// TI - Fresh frozen plasma versus prothrombin complex concentrate in patients with intracranial haemorrhage related to vitamin K antagonists (INCH): a randomised trial JO - Lancet Neurol VL - 15 UR - https://doi.org/10.1016/S1474-4422(16)00110-1 DO - 10.1016/S1474-4422(16)00110-1 ID - Steiner2016 ER - TY - JOUR AU - Eerenberg, E. S. AU - Kamphuisen, P. W. AU - Sijpkens, M. K. AU - Meijers, J. C. AU - Buller, H. R. AU - Levi, M. PY - 2011 DA - 2011// TI - Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects JO - Circulation VL - 124 UR - https://doi.org/10.1161/CIRCULATIONAHA.111.029017 DO - 10.1161/CIRCULATIONAHA.111.029017 ID - Eerenberg2011 ER - TY - JOUR AU - Pollack, C. V. AU - Reilly, P. A. AU - Eikelboom, J. AU - Glund, S. AU - Verhamme, P. AU - Bernstein, R. A. PY - 2015 DA - 2015// TI - Idarucizumab for Dabigatran Reversal JO - N Engl J Med VL - 373 UR - https://doi.org/10.1056/NEJMoa1502000 DO - 10.1056/NEJMoa1502000 ID - Pollack2015 ER - TY - JOUR AU - Pollack, C. V. AU - Reilly, P. A. AU - van Ryn, J. AU - Eikelboom, J. W. AU - Glund, S. AU - Bernstein, R. A. PY - 2017 DA - 2017// TI - Idarucizumab for dabigatran reversal - full cohort analysis JO - N Engl J Med VL - 377 UR - https://doi.org/10.1056/NEJMoa1707278 DO - 10.1056/NEJMoa1707278 ID - Pollack2017 ER - TY - JOUR AU - Hu, T. Y. AU - Vaidya, V. R. AU - Asirvatham, S. J. PY - 2016 DA - 2016// TI - Reversing anticoagulant effects of novel oral anticoagulants: role of ciraparantag, andexanet alfa, and idarucizumab JO - Vasc Health Risk Manag VL - 12 ID - Hu2016 ER - TY - JOUR AU - Connolly, S. J. AU - Milling, T. J. AU - Eikelboom, J. W. AU - Gibson, C. M. AU - Curnutte, J. T. AU - Gold, A. PY - 2016 DA - 2016// TI - Andexanet alfa for acute major bleeding associated with factor Xa inhibitors JO - N Engl J Med VL - 375 UR - https://doi.org/10.1056/NEJMoa1607887 DO - 10.1056/NEJMoa1607887 ID - Connolly2016 ER - TY - JOUR AU - Siegal, D. M. AU - Curnutte, J. T. AU - Connolly, S. J. AU - Lu, G. AU - Conley, P. B. AU - Wiens, B. L. PY - 2015 DA - 2015// TI - Andexanet alfa for the reversal of factor Xa inhibitor activity JO - N Engl J Med VL - 373 UR - https://doi.org/10.1056/NEJMoa1510991 DO - 10.1056/NEJMoa1510991 ID - Siegal2015 ER - TY - JOUR AU - Ansell, J. E. AU - Bakhru, S. H. AU - Laulicht, B. E. AU - Steiner, S. S. AU - Grosso, M. AU - Brown, K. PY - 2014 DA - 2014// TI - Use of PER977 to reverse the anticoagulant effect of edoxaban JO - N Engl J Med VL - 371 UR - https://doi.org/10.1056/NEJMc1411800 DO - 10.1056/NEJMc1411800 ID - Ansell2014 ER - TY - JOUR AU - Milling, T. J. AU - Refaai, M. A. AU - Goldstein, J. N. AU - Schneider, A. AU - Omert, L. AU - Harman, A. PY - 2016 DA - 2016// TI - Thromboembolic events after vitamin K antagonist reversal with 4-factor prothrombin complex concentrate: exploratory analyses of two randomized, plasma-controlled studies JO - Ann Emerg Med VL - 67 UR - https://doi.org/10.1016/j.annemergmed.2015.04.036 DO - 10.1016/j.annemergmed.2015.04.036 ID - Milling2016 ER - TY - JOUR AU - Laible, M. AU - Jenetzky, E. AU - Beynon, C. AU - Muller, O. J. AU - Sander, P. AU - Schuler, S. PY - 2016 DA - 2016// TI - Adverse events following international normalized ratio reversal in intracerebral hemorrhage JO - Cerebrovasc Dis VL - 42 UR - https://doi.org/10.1159/000448815 DO - 10.1159/000448815 ID - Laible2016 ER - TY - STD TI - Johansen M, Wikkelso A, Lunde J, Wetterslev J, Afshari A. Prothrombin complex concentrate for reversal of vitamin K antagonist treatment in bleeding and non-bleeding patients. Cochrane Database Syst Rev. 2015;7 https://doi.org/10.1002/14651858.CD14010555.pub14651852. ID - ref61 ER - TY - JOUR AU - Brekelmans, M. P. A. AU - Ginkel, K. V. AU - Daams, J. G. AU - Hutten, B. A. AU - Middeldorp, S. AU - Coppens, M. PY - 2017 DA - 2017// TI - Benefits and harms of 4-factor prothrombin complex concentrate for reversal of vitamin K antagonist associated bleeding: a systematic review and meta-analysis JO - J Thromb Thrombolysis VL - 44 UR - https://doi.org/10.1007/s11239-017-1506-0 DO - 10.1007/s11239-017-1506-0 ID - Brekelmans2017 ER - TY - STD TI - Schünemann H, Brożek J, Guyatt G, Oxman A, editors: GRADE handbook for grading quality of evidence and strength of recommendations.: The GRADE Working Group. Available from guidelinedevelopment.org/handbook.; Updated 2013. UR - http://guidelinedevelopment.org/handbook ID - ref63 ER - TY - STD TI - JPT H, Green S. Cochrane handbook for systematic reviews of interventions Version 5.1.0 (updated March 2011): The Cochrane Collaboration; 2011. Available from https://training.cochrane.org/handbook. UR - https://training.cochrane.org/handbook ID - ref64 ER - TY - JOUR AU - Lundh, A. AU - Bero, L. PY - 2017 DA - 2017// TI - The ties that bind JO - BMJ VL - 356 UR - https://doi.org/10.1136/bmj.j176 DO - 10.1136/bmj.j176 ID - Lundh2017 ER - TY - JOUR AU - Lundh, A. AU - Lexchin, J. AU - Mintzes, B. AU - Schroll, J. B. AU - Bero, L. PY - 2017 DA - 2017// TI - Industry sponsorship and research outcome JO - Cochrane Database Syst Rev VL - 2 ID - Lundh2017 ER - TY - JOUR AU - Gluud, L. L. PY - 2006 DA - 2006// TI - Bias in clinical intervention research JO - Am J Epidemiol VL - 163 UR - https://doi.org/10.1093/aje/kwj069 DO - 10.1093/aje/kwj069 ID - Gluud2006 ER - TY - JOUR AU - Kjaergard, L. L. AU - Villumsen, J. AU - Gluud, C. PY - 2001 DA - 2001// TI - Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses JO - Ann Intern Med VL - 135 UR - https://doi.org/10.7326/0003-4819-135-11-200112040-00010 DO - 10.7326/0003-4819-135-11-200112040-00010 ID - Kjaergard2001 ER - TY - JOUR AU - Moher, D. AU - Pham, B. AU - Jones, A. AU - Cook, D. J. AU - Jadad, A. R. AU - Moher, M. PY - 1998 DA - 1998// TI - Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? JO - Lancet VL - 352 UR - https://doi.org/10.1016/S0140-6736(98)01085-X DO - 10.1016/S0140-6736(98)01085-X ID - Moher1998 ER - TY - JOUR AU - Savovic, J. AU - Jones, H. AU - Altman, D. AU - Harris, R. AU - Juni, P. AU - Pildal, J. PY - 2012 DA - 2012// TI - Influence of reported study design characteristics on intervention effect estimates from randomised controlled trials: combined analysis of meta-epidemiological studies JO - Health Technol Assess VL - 16 UR - https://doi.org/10.3310/hta16350 DO - 10.3310/hta16350 ID - Savovic2012 ER - TY - JOUR AU - Schulz, K. F. AU - Chalmers, I. AU - Grimes, D. A. AU - Altman, D. G. PY - 1994 DA - 1994// TI - Assessing the quality of randomization from reports of controlled trials published in obstetrics and gynecology journals JO - JAMA VL - 272 UR - https://doi.org/10.1001/jama.1994.03520020051014 DO - 10.1001/jama.1994.03520020051014 ID - Schulz1994 ER - TY - JOUR AU - Egger, M. AU - Davey Smith, G. AU - Schneider, M. AU - Minder, C. PY - 1997 DA - 1997// TI - Bias in meta-analysis detected by a simple, graphical test JO - BMJ VL - 315 UR - https://doi.org/10.1136/bmj.315.7109.629 DO - 10.1136/bmj.315.7109.629 ID - Egger1997 ER - TY - JOUR AU - Lau, J. AU - Ioannidis, J. P. AU - Terrin, N. AU - Schmid, C. H. AU - Olkin, I. PY - 2006 DA - 2006// TI - The case of the misleading funnel plot JO - BMJ VL - 333 UR - https://doi.org/10.1136/bmj.333.7568.597 DO - 10.1136/bmj.333.7568.597 ID - Lau2006 ER - TY - JOUR AU - Tang, J. L. AU - Liu, J. L. PY - 2000 DA - 2000// TI - Misleading funnel plot for detection of bias in meta-analysis JO - J Clin Epidemiol VL - 53 UR - https://doi.org/10.1016/S0895-4356(99)00204-8 DO - 10.1016/S0895-4356(99)00204-8 ID - Tang2000 ER - TY - JOUR AU - Jakobsen, J. C. AU - Wetterslev, J. AU - Winkel, P. AU - Lange, T. AU - Gluud, C. PY - 2014 DA - 2014// TI - Thresholds for statistical and clinical significance in systematic reviews with meta-analytic methods JO - BMC Med Res Methodol VL - 14 UR - https://doi.org/10.1186/1471-2288-14-120 DO - 10.1186/1471-2288-14-120 ID - Jakobsen2014 ER - TY - JOUR AU - Sweeting, M. J. AU - Sutton, A. J. AU - Lambert, P. C. PY - 2004 DA - 2004// TI - What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data JO - Stat Med VL - 23 UR - https://doi.org/10.1002/sim.1761 DO - 10.1002/sim.1761 ID - Sweeting2004 ER - TY - JOUR AU - Cheng, J. i. AU - Pullenayegum, E. l. e. a. n. o. r. AU - Marshall, J. o. h. n. K. AU - Iorio, A. l. f. o. n. s. o. AU - Thabane, L. e. h. a. n. a. PY - 2016 DA - 2016// TI - Impact of including or excluding both-armed zero-event studies on using standard meta-analysis methods for rare event outcome: a simulation study JO - BMJ Open VL - 6 UR - https://doi.org/10.1136/bmjopen-2015-010983 DO - 10.1136/bmjopen-2015-010983 ID - Cheng2016 ER - TY - JOUR AU - Kuss, O. PY - 2015 DA - 2015// TI - Statistical methods for meta-analyses including information from studies without any events-add nothing to nothing and succeed nevertheless JO - Stat Med VL - 34 UR - https://doi.org/10.1002/sim.6383 DO - 10.1002/sim.6383 ID - Kuss2015 ER - TY - JOUR AU - Sharma, T. AU - Gotzsche, P. C. AU - Kuss, O. PY - 2017 DA - 2017// TI - The Yusuf-Peto method was not a robust method for meta-analyses of rare events data from antidepressant trials JO - J Clin Epidemiol VL - 91 UR - https://doi.org/10.1016/j.jclinepi.2017.07.006 DO - 10.1016/j.jclinepi.2017.07.006 ID - Sharma2017 ER - TY - JOUR AU - Castellini, G. AU - Nielsen, E. E. AU - Gluud, C. PY - 2016 DA - 2016// TI - Comment on: “Cell therapy for heart disease: Trial sequential analyses of two cochrane reviews” JO - Clinical Pharmacology & Therapeutics VL - 102 UR - https://doi.org/10.1002/cpt.536 DO - 10.1002/cpt.536 ID - Castellini2016 ER - TY - JOUR AU - Brok, J. AU - Thorlund, K. AU - Gluud, C. AU - Wetterslev, J. PY - 2008 DA - 2008// TI - Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses JO - J Clin Epidemiol VL - 61 UR - https://doi.org/10.1016/j.jclinepi.2007.10.007 DO - 10.1016/j.jclinepi.2007.10.007 ID - Brok2008 ER - TY - JOUR AU - Thorlund, K. AU - Devereaux, P. J. AU - Wetterslev, J. AU - Guyatt, G. AU - Ioannidis, J. P. AU - Thabane, L. PY - 2009 DA - 2009// TI - Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses? JO - Int J Epidemiol VL - 38 UR - https://doi.org/10.1093/ije/dyn179 DO - 10.1093/ije/dyn179 ID - Thorlund2009 ER - TY - BOOK AU - Thorlund, K. AU - Engstrøm, J. AU - Wetterslev, J. AU - Brok, J. AU - Imberger, G. AU - Gluud, C. PY - 2011 DA - 2011// TI - User manusal for trial sequential analysis (TSA) PB - Copenhagen Trial Unit CY - Denmark ID - Thorlund2011 ER - TY - JOUR AU - Wetterslev, J. AU - Jakobsen, J. C. AU - Gluud, C. PY - 2017 DA - 2017// TI - Trial sequential analysis in systematic reviews with meta-analysis JO - BMC Med Res Methodol VL - 17 UR - https://doi.org/10.1186/s12874-017-0315-7 DO - 10.1186/s12874-017-0315-7 ID - Wetterslev2017 ER - TY - JOUR AU - Wetterslev, J. AU - Thorlund, K. AU - Brok, J. AU - Gluud, C. PY - 2008 DA - 2008// TI - Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis JO - J Clin Epidemiol VL - 61 UR - https://doi.org/10.1016/j.jclinepi.2007.03.013 DO - 10.1016/j.jclinepi.2007.03.013 ID - Wetterslev2008 ER - TY - JOUR AU - Wetterslev, J. AU - Thorlund, K. AU - Brok, J. AU - Gluud, C. PY - 2009 DA - 2009// TI - Estimating required information size by quantifying diversity in random-effects model meta-analyses JO - BMC Med Res Methodol VL - 9 UR - https://doi.org/10.1186/1471-2288-9-86 DO - 10.1186/1471-2288-9-86 ID - Wetterslev2009 ER - TY - JOUR AU - Norman, G. R. AU - Sloan, J. A. AU - Wyrwich, K. W. PY - 2003 DA - 2003// TI - Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation JO - Med Care VL - 41 ID - Norman2003 ER - TY - JOUR AU - Goodman, S. N. PY - 1999 DA - 1999// TI - Toward evidence-based medical statistics. 2: the Bayes factor JO - Ann Intern Med VL - 130 UR - https://doi.org/10.7326/0003-4819-130-12-199906150-00019 DO - 10.7326/0003-4819-130-12-199906150-00019 ID - Goodman1999 ER - TY - JOUR AU - Goodman, S. N. PY - 2005 DA - 2005// TI - Introduction to Bayesian methods I: measuring the strength of evidence JO - Clin Trials VL - 2 UR - https://doi.org/10.1191/1740774505cn098oa DO - 10.1191/1740774505cn098oa ID - Goodman2005 ER - TY - JOUR AU - Jakobsen, J. C. AU - Gluud, C. AU - Winkel, P. AU - Lange, T. AU - Wetterslev, J. PY - 2014 DA - 2014// TI - The thresholds for statistical and clinical significance - a five-step procedure for evaluation of intervention effects in randomised clinical trials JO - BMC Med Res Methodol VL - 14 UR - https://doi.org/10.1186/1471-2288-14-34 DO - 10.1186/1471-2288-14-34 ID - Jakobsen2014 ER - TY - JOUR AU - Nguyen, T. L. AU - Collins, G. S. AU - Lamy, A. AU - Devereaux, P. J. AU - Daures, J. P. AU - Landais, P. PY - 2017 DA - 2017// TI - Simple randomization did not protect against bias in smaller trials JO - J Clin Epidemiol VL - 84 UR - https://doi.org/10.1016/j.jclinepi.2017.02.010 DO - 10.1016/j.jclinepi.2017.02.010 ID - Nguyen2017 ER - TY - JOUR AU - Jakobsen, J. C. AU - Gluud, C. AU - Wetterslev, J. AU - Winkel, P. PY - 2017 DA - 2017// TI - When and how should multiple imputation be used for handling missing data in randomised clinical trials - a practical guide with flowcharts JO - BMC Med Res Methodol VL - 17 UR - https://doi.org/10.1186/s12874-017-0442-1 DO - 10.1186/s12874-017-0442-1 ID - Jakobsen2017 ER - TY - JOUR AU - Mavridis, D. AU - Chaimani, A. AU - Efthimiou, O. AU - Leucht, S. AU - Salanti, G. PY - 2014 DA - 2014// TI - Addressing missing outcome data in meta-analysis JO - Evid Based Ment Health VL - 17 UR - https://doi.org/10.1136/eb-2014-101900 DO - 10.1136/eb-2014-101900 ID - Mavridis2014 ER - TY - JOUR AU - investigators, G. U. S. T. O. PY - 1993 DA - 1993// TI - An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction JO - N Engl J Med VL - 329 UR - https://doi.org/10.1056/NEJM199309023291001 DO - 10.1056/NEJM199309023291001 ID - investigators1993 ER - TY - JOUR AU - Eikelboom, J. W. AU - Mehta, S. R. AU - Anand, S. S. AU - Xie, C. AU - Fox, K. A. AU - Yusuf, S. PY - 2006 DA - 2006// TI - Adverse impact of bleeding on prognosis in patients with acute coronary syndromes JO - Circulation VL - 114 UR - https://doi.org/10.1161/CIRCULATIONAHA.106.612812 DO - 10.1161/CIRCULATIONAHA.106.612812 ID - Eikelboom2006 ER - TY - STD TI - Nielsen EE, Feinberg J, Greenhalgh J, Hounsome J, Sethi NJ, Safi S, et al. Drug-eluting stents versus bare-metal stents for stable ischaemic heart disease. Cochrane Database Syst Rev. 2016;12. https://doi.org/10.1002/14651858.CD012480. ID - ref96 ER - TY - JOUR AU - Schulz, K. F. AU - Chalmers, I. AU - Hayes, R. J. AU - Altman, D. G. PY - 1995 DA - 1995// TI - Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials JO - JAMA VL - 273 UR - https://doi.org/10.1001/jama.1995.03520290060030 DO - 10.1001/jama.1995.03520290060030 ID - Schulz1995 ER - TY - JOUR AU - Savovic, J. AU - Jones, H. E. AU - Altman, D. G. AU - Harris, R. J. AU - Juni, P. AU - Pildal, J. PY - 2012 DA - 2012// TI - Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials JO - Ann Intern Med VL - 157 UR - https://doi.org/10.7326/0003-4819-157-6-201209180-00537 DO - 10.7326/0003-4819-157-6-201209180-00537 ID - Savovic2012 ER - TY - JOUR AU - Guyatt, G. H. AU - Oxman, A. D. AU - Vist, G. E. AU - Kunz, R. AU - Falck-Ytter, Y. AU - Alonso-Coello, P. PY - 2008 DA - 2008// TI - GRADE: an emerging consensus on rating quality of evidence and strength of recommendations JO - BMJ VL - 336 UR - https://doi.org/10.1136/bmj.39489.470347.AD DO - 10.1136/bmj.39489.470347.AD ID - Guyatt2008 ER - TY - JOUR AU - Home, P. D. PY - 2013 DA - 2013// TI - Validity of meta-analysis in diabetes: we need to be aware of its limitations JO - Diabetes Care VL - 36 UR - https://doi.org/10.2337/dc12-2449 DO - 10.2337/dc12-2449 ID - Home2013 ER - TY - JOUR AU - Bennetts, M. AU - Whalen, E. AU - Ahadieh, S. AU - Cappelleri, J. C. PY - 2017 DA - 2017// TI - An appraisal of meta-analysis guidelines: how do they relate to safety outcomes? JO - Res Synth Methods VL - 8 UR - https://doi.org/10.1002/jrsm.1219 DO - 10.1002/jrsm.1219 ID - Bennetts2017 ER - TY - JOUR AU - Hernandez, A. V. AU - Walker, E. AU - Ioannidis, J. P. AU - Kattan, M. W. PY - 2008 DA - 2008// TI - Challenges in meta-analysis of randomized clinical trials for rare harmful cardiovascular events: the case of rosiglitazone JO - Am Heart J VL - 156 UR - https://doi.org/10.1016/j.ahj.2008.03.002 DO - 10.1016/j.ahj.2008.03.002 ID - Hernandez2008 ER -